Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionEvexia Wealth Llc
Latest Disclosed Ownership2,764 shares
Latest Disclosed Value $ 278,282
Evexia Wealth Llc reports 0.58% increase in ownership of ABL / Abbott Laboratories

On April 16, 2026 - Evexia Wealth Llc filed a 13F-HR form disclosing ownership of 2,764 shares of Abbott Laboratories (DE:ABL) valued at $245,498 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 16, 2026 disclosing 2,748 shares of Abbott Laboratories. This represents a change in shares of 0.58% during the quarter. The current value of the position is $207,908 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-16 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 2,764 16 0.58 278 -18.95 0.0765
2026-01-16 2025-12-31 13F ABBOTT LABS COM 002824100 2,748 12 0.44 344 -4.46 0.0960
2025-11-12 2025-09-30 13F ABBOTT LABS COM 002824100 2,736 12 0.44 359 6.85 0.1076
2025-07-23 2025-06-30 13F ABBOTT LABS COM 002824100 2,724 12 0.44 337 -2.33 0.1059
2025-04-11 2025-03-31 13F ABBOTT LABS COM 002824100 2,712 12 0.44 344 -1.15 0.1252
2025-02-13 2024-12-31 13F ABBOTT LABS COM 002824100 2,700 13 0.48 348 14.47 0.1181
2024-10-10 2024-09-30 13F ABBOTT LABS COM 002824100 2,687 14 0.52 305 9.75 0.1080
2024-07-31 2024-06-30 13F ABBOTT LABS COM 002824100 2,673 14 0.53 277 -4.48 0.1041
2024-05-03 2024-03-31 13F ABBOTT LABS COM 002824100 2,659 12 0.45 290 -2.03 0.1195
2024-02-06 2023-12-31 13F ABBOTT LABS COM 002824100 2,647 14 0.53 297 20.33 0.1254
2023-10-30 2023-09-30 13F ABBOTT LABS COM 002824100 2,633 12 0.46 246 -16.61 0.1248
2023-07-31 2023-06-30 13F ABBOTT LABS COM 002824100 2,621 13 0.50 296 2.43 0.1421
2023-05-15 2023-03-31 13F ABBOTT LABS COM 002824100 2,608 2,608 289 0.1557
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.